#384 Updates in Chronic Kidney Disease with Dr. Joel Topf

Stay up-to-date with advances in chronic kidney disease (CKD)! Join our esteemed Chief of Nephrology at Kashlak Memorial Hospital, Dr. Joel Topf, as he leads us through the latest on SGLT2 inhibitors, finerenone, potassium binders, and treatment of CKD-associated metabolic acidosis.Claim free CME for this episode at curbsiders.vcuhealth.org!Episodes | Subscribe | Spotify | YouTube | Mailing List | [email protected] | Swag! | Free CME!Show Segments Intro, disclaimer, guest bio Case from Kashlak SGLT2i: when to initiate SGLT2i: adverse effects Finerenone Potassium binders Treatment of CKD-associated metabolic acidosis  Outro Credits Writer, Producer, Show Notes, Infographics, and Cover Art: Malini Gandhi Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Leah Witt MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Dr. Joel Topf MD Sponsor: Better HelpVisit betterhelp.com/curb today to get 10% off your first month. Sponsor: Birch Living Birch is giving 20% off all mattresses and 2 free eco-rest pillows at birchliving.com/curb. Sponsor: PanaceaFinancialVisit panaceafinancial.com to open a free account.  Full transcript available HERE